Liver
26
3
3
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
2 terminated out of 26 trials
81.8%
-4.7% vs benchmark
4%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (26)
Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
3D Liver Volumetry
Augmented Reality Real-Time Guidance for MRI-Guided Interventions
AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region
Clinical Trial to Evaluate the Effectiveness and Safety of a Remote Automated Ultrasound Diagnostic System for Automated Ultrasound Examinations: a Prospective, Multicenter Study
SALT for Patients With Hepatic Cirrhosis
Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over Trial
Effects of Maternal Smoking on Fetal Liver Circulation
DEBOXA for Inoperable NET Liver Metastases
Relationship Between Contrast Media Volume and Tube Voltage in CT for Optimal Liver Enhancement, Based on Body Weight.
Hepatic Artery Infusion Pump for NPC Liver Metastases
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.
A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver
Liver Transplantation for Cholangiocarcinoma
Primovist Regulatory Post Marketing Surveillance (PMS)
Safety Study of Pioglitazone Compared To Glyburide on Liver Function